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Abstract
Recent studies indicate that mitochondrial dysfunction plays a role
in the pathogenesis of a number of disease states. The importance
of these organelles in shock and multiple organ dysfunction is of
particular interest to those caring for the critically ill. Mitochondria
have their own unique DNA (mtDNA) that encodes 13 essential
subunits of electron transport chain enzymes, two ribosomal RNAs
and 22 transfer RNAs. Importantly, mtDNA is especially sus-
ceptible to deletions, rearrangements and mutations because it is
not bound by histones and lacks the extensive repair machinery
present in the nucleus. The study by Côté et al. in this issue of
Critical Care examines changes in mtDNA in critically ill patients.
The results support further investigation into the role of mtDNA in
the critically ill.
The role of mitochondria in systemic disease has been under-
appreciated, and in this issue of Critical Care, Côté et al. [1]
examine changes in mitochondrial DNA (mtDNA) in critically
ill patients. However, recent evidence has demonstrated
impaired oxidative phosphorylation and defective mitochon-
drial homeostasis in a number of disorders [2,3]. Although
the concept of mitochondrial dysfunction and bioenergetic
failure during sepsis and shock is not new, recent
experimental approaches have yielded novel and interesting
findings [4-6]. These have led us and others to propose
intriguing hypotheses regarding the pathogenesis of acquired
mitochondrial dysfunction in a variety of disease states.
In this issue, Côté et al. examine changes in mtDNA in
critically ill patients. Their data demonstrate a 30% reduction
in the ratio of mtDNA to nuclear DNA (nDNA) in circulating
cells of 28 critically ill patients when compared to healthy
controls [1]. More importantly, this ratio increased by almost
30% at four days in survivors while non-survivors experienced
a further reduction in the mtDNA/nDNA ratio. One might
conclude that loss or failed synthesis of mtDNA is a unifying
cause of sepsis-induced mitochondrial dysfunction and that
clinicians could use mtDNA copy number to predict mortality
during critical illness. This requires a more detailed
examination of mtDNA heterogeneity and mitochondrial
regeneration.
Each mitochondrion has 2-10 copies of its own circular
genome. These encode for 13 essential subunits of electron
transport chain enzymes, two ribosomal RNAs and 22
transfer RNAs [7]. The structural subunits of the electron
transport complexes and other mitochondrial proteins arise
from nuclear genes [8]. Thus, expression of the genes
encoding mitochondrial enzyme complexes is under dual
control. mtDNA is particularly prone to deletions, rearrange-
ments and mutations caused by oxidative stress because it is
unbound by histones and because these organelles lack the
extensive repair systems seen in the nucleus [9]. Therefore,
reactive oxygen species produced during oxidative
phosphorylation in a variety of disease states can damage
mtDNA and mitochondrial proteins. This would lead to
decreased ATP production and enhanced programmed cell
death [7].
Heteroplasmy describes the coexistence of both mutant
mtDNA and wild-type, non-mutant mtDNA within the same
cell [8]. If the mitochondrial genome drift results in a signifi-
cant amount of mutant mtDNA, cells exhibit reduced energy
capacity and organs become dysfunctional [7]. The threshold
for these processes is lower in highly oxidative tissue such as
brain, heart, skeletal muscle, retina, kidney and endocrine
organs [8]. This threshold effect explains tissue-related
variability in the clinical presentation of both inherited and
acquired mitochondrial diseases [8].
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Impaired mitochondrial biogenesis represents an additional
manner in which mitochondria may contribute to acquired
disorders. Biogenesis includes all of the processes needed
for mitochondrial homeostasis and division. It requires precise
coordination between both mitochondrial and nuclear-
encoded gene products as well as maintenance and
replication of mtDNA [10,11]. Recent investigation demon-
strates that experimental murine sepsis caused mitochondrial
oxidative stress, a loss of mtDNA copy number and
depressed basal metabolism in the septic liver [12]. In the
recovery phase, mitochondrial biogenesis restored mtDNA
copy number and oxidative metabolism.
Our understanding of bioenergetic failure in sepsis and shock
has been largely limited by interpretation of early investiga-
tions. These studies assumed that preservation of cellular
ATP indicated intact electron transport [13,14]. However,
more recent data make it clear that cells can adapt and
maintain viability by down-regulating oxygen consumption,
energy requirements and ATP demand [15,16]. In the heart
this response is called myocardial hibernation and results in
cardiomyocyte hypocontractility with preserved cellular ATP
[15]. Hibernating cells maintain ATP levels in the setting of
defective oxidative phosphorylation by ceasing nonessential
cellular functions to limit ATP utilization [15,16]. At the organ
level, this down-regulated metabolic state may manifest as
“organ dysfunction” or “organ failure”. During hypoxia,
ischemia and in early or non-fatal sepsis, such a response
appears to be adaptive and often reversible as cells at risk
maintain viability and recover after reoxygenation and
reperfusion. Our data, however, indicate that during lethal
sepsis a similar hibernation response, while initially adaptive,
may become problematic as cells remain persistently down-
regulated, enzyme complex content and activity decrease and
organ failure becomes irreversible [3,4]. This may result from
an acquired defect in gene expression and/or functional
activity of any of the electron transport enzymes [17]. Our
data suggest that persistently impaired mitochondrial gene
expression may represent the irreversible defect that leads to
organ failure and death.
The hypothesis that therapeutically enhancing mitochondrial
biogenesis could improve survival is fascinating, especially if
defects in mitochondrial replication and mtDNA synthesis
also occur in cells of solid organs. Based on recent reports, it
is conceivable that stem cells or fibroblasts may be able to
restore defective mitochondria in neighboring cells with wild-
type mtDNA [18]. Thus, future investigation should focus on
increasing and restoring wild-type mtDNA to restore cellular
oxidative capacity and organ function in sepsis and shock.
What is most exciting is that we are still gaining insight into
this billion year old, complex organelle. However, it remains
unclear if mitochondrial impairment causes organ dys-
function, is protective against impending organ injury or is an
epiphenomenon. The data presented to date have not directly
addressed this issue. These questions demand a more
exhaustive investigation of the fascinating processes of
mitochondrial biogenesis and homeostasis during both health
and disease.
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